Disposition of tobramycin in patients with cystic fibrosis: A prospective controlled study
- 1 July 1984
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 105 (1), 117-124
- https://doi.org/10.1016/s0022-3476(84)80375-3
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Pharmacokinetics of tobramycin in cystic fibrosisThe Journal of Pediatrics, 1982
- Dosing implications of altered gentamicin disposition in patients with cystic fibrosisThe Journal of Pediatrics, 1982
- Pharmacokinetics of netilmicin in children with and without cystic fibrosisAntimicrobial Agents and Chemotherapy, 1981
- The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosisThe Journal of Pediatrics, 1981
- Double-Blind Comparison of the Nephrotoxicity and Auditory Toxicity of Gentamicin and TobramycinNew England Journal of Medicine, 1980
- Aminoglycoside clearance inpatients with cystic fibrosisThe Journal of Pediatrics, 1979
- Why Monitor Serum Levels of Gentamicin?Clinical Pharmacokinetics, 1978
- The pharmacokinetics of amikacin in childrenThe Journal of Pediatrics, 1977
- Tobramycin Therapy of Infections Due to Pseudomonas aeruginosa in Patients with Cystic Fibrosis: Effect of Dosage and Concentration of Antibiotic in SputumThe Journal of Infectious Diseases, 1976
- Long-Term Study of One Hundred Five Patients with Cystic FibrosisA.M.A. Journal of Diseases of Children, 1958